News

To date, Diffusion Pharmaceuticals has raised $13.1 million in private equity and has received $2.6 million in government R&D funding from the Office of Naval Research, bringing the

Eisai has said that the Travelmin churop grape flavor prevents and alleviates symptoms of motion sickness such as dizziness and nausea with antihistaminic component (d-chlorpheniramine maleate) and anticholinergic

Dr Durnell has been with Gentel for over a year where he served as the vice president of commercial operations. In his new role, Dr Durnell will be

Under the terms of the agreement, Trevena has received exclusive worldwide rights to sublicense active compounds resulting from the collaboration. Ligand expects to screen 24 targets over two

CGEN-327 is a previously unknown splice variant of the HE4 (Human Epididymis Protein 4) gene, which is a known biomarker for ovarian cancer. The company has also entered

Each unit will consist of one common share and one-half of one share purchase warrant. Each whole share purchase warrant shall entitle the holder to acquire one common

The additional contribution will be applied to the development of the company’s novel antibiofilm topical wound gel containing its patented DispersinB technology. DispersinB wound gel is being developed

ROX-888 is an intranasal formulation of ketorolac, a non-steroidal anti-inflammatory drug, designed to provide ambulatory patients with a convenient, potent, and fast-acting option for acute pain relief, without

Once-daily fluticasone furoate (FF) produced statistically significant improvements in patients’ lung function (trough FEV1) compared to placebo (p < 0.05) in each of the three study populations and